Evaluation of The Effect of Nanocurcumin on Treatment of Tinnitus

Evaluation of The Effect of Nanocurcumin on Treatment of Tinnitus:A Triple Blinded Randomized Clinical Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190916044785N1

Enrollment

Registered

2019-10-20

Start date

2019-09-23

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus. Tinnitus

Interventions

Intervention 1: The Intervention group will Consume Sina 80 mg Nano curcumin Supplement with Meals for 21 days . Intervention 2: Control group: The Control group will consume Placebo capsul once a da

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Unilateral or Bilateral Subjective Tinnitus Age Range: 18-65 Year Patients do not have Pregnancy and Breastfeeding Patients do not have Acute or Chronic Ear Infection Patients do not have Rheumatologic Diseases, Vasculitis, Acoustic Neuroma, Known Neurological Disorders and Ear Surgery Patients not taking Immunosuppressants such as Interferons, Corticosteroids, Anticonvulsants and Sedatives before starting the study

Exclusion criteria

Exclusion criteria: Patients who do not willing to enter the study

Design outcomes

Primary

Measure	Time frame
Tinnitus Handicap Inventory. Timepoint: Before and after 21 days of Medicine Consumption. Method of measurement: Tinitus Matching Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Farahani

Hamedan University of Medical Sciences

Zfarahani93@ymail.com+98 81 3264 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026